» Articles » PMID: 15893919

Controlled-release Matrix Tablets of Ibuprofen Using Cellulose Ethers and Carrageenans: Effect of Formulation Factors on Dissolution Rates

Overview
Specialty Pharmacology
Date 2005 May 17
PMID 15893919
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The study was conducted to investigate the effects of carrageenans, and cellulose ethers on the drug release rates of ibuprofen controlled-release tablet matrices prepared by direct compression. Polymer blends containing carrageenans or cellulose ethers were used for the formulation and the effect of varying the polymer concentration on the release of the drug was studied. Other factors such as changes in surface topography of the matrices due to hydration were observed using a cryogenic scanning electron microscopy technique. Multiple regression analysis was used to predict the time for 50% release (t50) as a function of the concentration of the polymers used. Most of the formulations showed linear release profiles (r(2)>or=0.96-0.99) and sustained the release of ibuprofen over 12-16 h. The highest t50 (9.3 h) was for the formulation that contained a blend of 1:2 ratio of Viscarin and HPMC, while the lowest (3 h) was for the matrices that contained a 2:1 ratio of methylcellulose and Gelcarin. The majority of the matrix tablets that contained 10% polymer disintegrated prematurely. Of all the polymer blends that were investigated, the combination of Viscarin and HPMC gave almost linear release profiles over the entire range of concentration that was studied. The least effective combination was methylcellulose in combination with HPMC. Most of the formulations released ibuprofen by an anomalous (non-Fickian) transport mechanism, except those matrices that contained methylcellulose and Gelcarin (in a 1:1 and 1:2 ratio), which showed zero-order release.

Citing Articles

Nanotechnology-driven improvisation of red algae-derived carrageenan for industrial and bio-medical applications.

James J, Verma M, Sharma N World J Microbiol Biotechnol. 2023; 40(1):4.

PMID: 37923917 DOI: 10.1007/s11274-023-03787-x.


Algal Phycocolloids: Bioactivities and Pharmaceutical Applications.

Lomartire S, Goncalves A Mar Drugs. 2023; 21(7).

PMID: 37504914 PMC: 10381318. DOI: 10.3390/md21070384.


pH-Responsive Hydrogel Beads Based on Alginate, κ-Carrageenan and Poloxamer for Enhanced Curcumin, Natural Bioactive Compound, Encapsulation and Controlled Release Efficiency.

Postolovic K, Antonijevic M, Ljujic B, Kovacevic M, Gazdic Jankovic M, Stanic Z Molecules. 2022; 27(13).

PMID: 35807288 PMC: 9268575. DOI: 10.3390/molecules27134045.


Statistical Design of Sustained-Release Tablet Extract and Bioconverted Mulberry Leaf Extract for Anti-Obesity.

Lee H, Na Y, Han M, Pham T, Lee H, Lee H Pharmaceutics. 2020; 12(10).

PMID: 33003619 PMC: 7600061. DOI: 10.3390/pharmaceutics12100932.


In-Depth Study into Polymeric Materials in Low-Density Gastroretentive Formulations.

Iglesias N, Galbis E, Romero-Azogil L, Benito E, Lucas R, Garcia-Martin M Pharmaceutics. 2020; 12(7).

PMID: 32645909 PMC: 7408198. DOI: 10.3390/pharmaceutics12070636.